查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632738

药物再利用人工智慧市场：2033 年市场分析与预测 - 按类型、产品、服务、技术、组件、应用、最终用户、部署、阶段、解决方案

AI for Drug Repurposing Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Component, Application, End User, Deployment, Stage, Solutions
出版日期: | 出版商: Global Insight Services | 英文 392 Pages | 商品交期: 3-5个工作天内

价格
简介目录

药物再利用的人工智慧市场预计将从 2024 年的 12 亿美元成长到 2034 年的 47 亿美元，复合年增长率约为 13.9%。

药物再利用人工智慧市场涉及应用人工智慧技术来识别现有药物的新治疗用途。这个创新领域利用机器学习演算法、数据分析和计算生物学来简化药物发现过程、降低成本并加快上市时间。它在简化药物研究、解决未满足的医疗需求和优化医疗保健产业的资源利用方面发挥着至关重要的作用。

受对经济高效药物开发流程的需求推动，药物再利用的人工智慧市场正经历强劲成长。肿瘤学正在引领市场，因为人工智慧支援的药物再利用为癌症治疗的创新提供了一条有希望的途径。由于对神经退化性疾病新疗法的迫切需求，神经病学成为表现第二好的细分领域。从区域来看，北美占据主导地位，得益于技术进步和支持性监管环境。欧洲在人工智慧研究方面投入了大量资金，并专注于医疗保健创新，因此很可能会成为其追随者。在其他国家中，美国正在利用其庞大的製药基础设施和人工智慧专业知识来保持领先地位。德国凭藉其强大的研发生态系统和战略伙伴关係在欧洲脱颖而出。人工智慧与製药公司之间日益增多的合作进一步推动了市场的成长，旨在充分释放人工智慧在药物再利用方面的潜力。

2023年，药物再利用的AI市场表现出强劲的规模，重点在于提高药物发现效率。市场分为技术、应用和最终用户类别。机器学习领域占据了 45% 的市场占有率，因为它具有分析复杂资料集的能力。其次是自然语言处理（30%）和深度学习（25%）。製药业成为主要的终端用户，占市场规模的 60%。这一优势源于扩大采用人工智慧技术来加速药物再利用过程并降低成本。

领先公司正在利用人工智慧简化药物开发流程，从而形成竞争发展，其中包括 BenevolentAI、Insilico Medicine 和 Atomwise。监管框架，尤其是 FDA 和 EMA，至关重要，因为它们制定了严格的指导方针以确保安全性和有效性。未来预测表明，由于技术进步和研发投入的增加，到 2033 年复合年增长率将达到 13%。人工智慧在缩短药物开发时间和成本方面的作用是一个关键因素，而且市场有望成长。然而，资料隐私问题和法规合规性等课题仍然是主要障碍。人工智慧和大数据分析的融合有望提高药物再利用策略的准确性并释放更多机会。

北美在药物再利用人工智慧市场占据主导地位。该地区受益于先进的医疗保健基础设施和大量的研发投资。美国公司正在引领创新并推动市场成长。主要行业参与者的存在增强了该地区的竞争力。

在欧洲，德国、英国等国已率先利用人工智慧进行药物研发，许多其他国家也纷纷跟进。强大的监管框架和合作研究计划正在支持市场扩张。欧盟对医疗保健创新的关注进一步支持了成长。

亚太地区正成为一个充满希望的市场。中国和印度等国家的快速技术进步将推动其采用。该地区各国政府正在投资人工智慧研究，以创造有利于成长的环境。慢性病的增加也推动了需求。

在拉丁美洲，市场正逐渐获得关注。巴西和墨西哥在利用人工智慧加强药物再利用方面处于领先地位。学术机构和产业参与者的协作发展正在支持市场发展。

中东和非洲存在着新的商机。阿拉伯联合大公国等国家正在投资人工智慧技术，以推进医疗保健解决方案。预计战略合作伙伴关係和政府举措将在未来几年推动市场成长。

目录

第 1 章 药物再利用人工智慧市场概述

  • 研究目标
  • 人工智慧药物再利用市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第 2 章 执行摘要

第3章 有关市场的重要考量因素

第4章 药物再利用的人工智慧市场前景

  • 药物再利用人工智慧市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P型号
  • 安索夫矩阵

第5章 药物再利用人工智慧的市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例分析
  • 价格分析
  • 监管状况
  • 供应链分析
  • 竞品分析
  • 最近的发展

第6章 药物再利用人工智慧的市场规模

  • 药物再利用人工智慧的市场规模（以价值计算）
  • 药物再利用人工智慧的市场规模（按数量计算）

第7章 药物再利用人工智慧市场按类型划分

  • 市场概况
  • 机器学习
  • 深度学习
  • 自然语言处理
  • 其他

第8章 药物再利用人工智慧市场（依产品划分）

  • 市场概况
  • 软件平台
  • 人工智慧模型
  • 数据分析工具
  • 其他

第9章 药物再利用人工智慧市场（按服务）

  • 市场概况
  • 咨询服务
  • 综合服务
  • 维修服务
  • 培训和支持
  • 其他

第 10 章 药物再利用人工智慧市场（按技术）

  • 市场概况
  • 基于云的
  • 本地
  • 混合
  • 其他

第 11 章 药物再利用人工智慧市场按组成部分

  • 市场概况
  • 硬体
  • 软体
  • 服务
  • 其他

第 12 章 药物再利用的人工智慧市场（按应用）

  • 市场概况
  • 癌症领域
  • 循环系统
  • 神经病学
  • 感染
  • 罕见疾病
  • 其他

第 13 章 药物再利用人工智慧市场（依最终用户划分）

  • 市场概况
  • 製药公司
  • 生物技术公司
  • 研究机构
  • 合同研究所
  • 其他

第 14 章 药物再利用人工智慧市场（按部署）

  • 市场概况
  • 云
  • 本地
  • 其他

第 15 章 药物再利用人工智慧市场分阶段

  • 市场概况
  • 药物发现
  • 临床前研究
  • 临床试验
  • 上市后监测
  • 其他

第 16 章：药物再利用市场的人工智慧解决方案

  • 市场概况
  • 药物发现
  • 药物开发
  • 药物重复使用
  • 其他

第 17 章 各地区药物再利用人工智慧市场

  • 概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合酋长国
    • 南非
    • 其他中东/非洲

第18章 竞争格局

  • 概述
  • 市场占有率分析
  • 大公司定位
  • 竞争领导映射
  • 供应商基准测试
  • 对标发展策略

第19章 公司简介

  • BioNTech
  • Moderna
  • Gritstone Oncology
  • Neon Therapeutics
  • Immunicum
  • Ultimovacs
  • Vaccibody
  • Transgene
  • Nouscom
  • Agenus
  • AgenTus Therapeutics
  • OncoSec Medical
  • Inovio Pharmaceuticals
  • Hookipa Pharma
  • Aduro Biotech
  • CureVac
  • Genexine
  • OncoPep
  • Vaximm
  • eTheRNA Immunotherapies
简介目录
Product Code: GIS10829

The AI for Drug Repurposing market is set to expand from $1.2 billion in 2024 to $4.7 billion by 2034, with a CAGR of approximately 13.9%.

The AI for Drug Repurposing Market encompasses the application of artificial intelligence technologies to identify new therapeutic uses for existing drugs. This innovative sector leverages machine learning algorithms, data analytics, and computational biology to streamline drug discovery processes, reduce costs, and accelerate time-to-market. It plays a pivotal role in enhancing pharmaceutical research efficiency, addressing unmet medical needs, and optimizing resource utilization within the healthcare industry.

The AI for Drug Repurposing Market is witnessing robust growth, driven by the need for cost-effective and efficient drug development processes. The oncology segment leads the market, as AI-driven repurposing offers promising avenues for cancer treatment innovations. Neurology emerges as the second-highest performing sub-segment, propelled by the urgent need for novel therapies in neurodegenerative diseases. Regionally, North America dominates, benefiting from substantial technological advancements and a supportive regulatory environment. Europe follows as a strong contender, with significant investments in AI research and a focus on healthcare innovation. Within countries, the United States remains at the forefront, leveraging its vast pharmaceutical infrastructure and AI expertise. Germany stands out in Europe, driven by its robust R&D ecosystem and strategic partnerships. The market's growth is further augmented by increasing collaborations between AI firms and pharmaceutical companies, aiming to unlock the full potential of AI in drug repurposing.

In 2023, the AI for Drug Repurposing Market demonstrated a robust volume, with a significant focus on enhancing drug discovery efficiency. The market was segmented into technology, application, and end-user categories. The machine learning segment accounted for 45% of the market share, driven by its capacity to analyze complex datasets. Natural language processing followed with a 30% share, while deep learning constituted 25%. The pharmaceutical sector emerged as the dominant end-user, representing 60% of the market volume. This dominance is attributed to the increasing adoption of AI technologies to expedite drug repurposing processes and reduce costs.

Competitive dynamics are shaped by key players such as BenevolentAI, Insilico Medicine, and Atomwise, which are leveraging AI to streamline drug development. Regulatory frameworks, especially from the FDA and EMA, are pivotal, as they set stringent guidelines ensuring safety and efficacy. The market is poised for growth, with AI's role in reducing drug development timelines and costs being a critical factor. However, challenges such as data privacy concerns and regulatory compliance remain significant hurdles. The integration of AI with big data analytics is anticipated to unlock further opportunities, enhancing precision in drug repurposing strategies.

North America dominates the AI for drug repurposing market. The region benefits from advanced healthcare infrastructure and significant R&D investments. Companies in the United States lead innovation, driving market growth. The presence of key industry players enhances the region's competitive edge.

Europe follows closely, with countries like Germany and the United Kingdom spearheading efforts in AI-driven drug discovery. Strong regulatory frameworks and collaborative research initiatives support market expansion. The European Union's focus on healthcare innovation further propels growth.

Asia Pacific emerges as a promising market. Rapid technological advancements in countries such as China and India boost adoption. Governments in the region invest in AI research, fostering a conducive environment for growth. The increasing prevalence of chronic diseases also fuels demand.

In Latin America, the market is gradually gaining traction. Brazil and Mexico are at the forefront, leveraging AI to enhance drug repurposing efforts. Collaboration between academic institutions and industry players supports market development.

The Middle East and Africa present emerging opportunities. Countries like the United Arab Emirates are investing in AI technologies to advance healthcare solutions. Strategic partnerships and government initiatives are expected to drive market growth in the coming years.

Key Companies

Insilico Medicine, Atomwise, Benevolent AI, Healx, Recursion Pharmaceuticals, Cyto Reason, Exscientia, Pharm AI, Bio Xcel Therapeutics, Deep Genomics, Insitro, Verge Genomics, GNS Healthcare, Numerate, Nu Medii, One Three Biotech, Aria Pharmaceuticals, Standigm, BERG Health, Cyclica

Sources

National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), National Center for Advancing Translational Sciences (NCATS), Biomedical Advanced Research and Development Authority (BARDA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Innovative Medicines Initiative (IMI), National Institute for Health and Care Excellence (NICE), National Health Service (NHS) Digital, DrugBank, PubChem, ClinicalTrials.gov, The American Association for Cancer Research (AACR) Annual Meeting, The International Society for Computational Biology (ISCB) Conference on Intelligent Systems for Molecular Biology (ISMB), The American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, The Drug Information Association (DIA) Global Annual Meeting, The European Conference on Computational Biology (ECCB), The International Conference on Machine Learning (ICML), The Conference on Neural Information Processing Systems (NeurIPS)

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: AI for Drug Repurposing Market Overview

  • 1.1 Objectives of the Study
  • 1.2 AI for Drug Repurposing Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by Solutions
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by Solutions
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: AI for Drug Repurposing Market Outlook

  • 4.1 AI for Drug Repurposing Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: AI for Drug Repurposing Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: AI for Drug Repurposing Market Size

  • 6.1 AI for Drug Repurposing Market Size, by Value
  • 6.2 AI for Drug Repurposing Market Size, by Volume

7: AI for Drug Repurposing Market, by Type

  • 7.1 Market Overview
  • 7.2 Machine Learning
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Deep Learning
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Natural Language Processing
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: AI for Drug Repurposing Market, by Product

  • 8.1 Market Overview
  • 8.2 Software Platforms
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 AI Models
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Data Analysis Tools
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: AI for Drug Repurposing Market, by Services

  • 9.1 Market Overview
  • 9.2 Consulting Services
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Integration Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Maintenance Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Training and Support
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: AI for Drug Repurposing Market, by Technology

  • 10.1 Market Overview
  • 10.2 Cloud-Based
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 On-Premise
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Hybrid
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: AI for Drug Repurposing Market, by Component

  • 11.1 Market Overview
  • 11.2 Hardware
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Software
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Services
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: AI for Drug Repurposing Market, by Application

  • 12.1 Market Overview
  • 12.2 Oncology
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Cardiology
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Neurology
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Infectious Diseases
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Rare Diseases
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: AI for Drug Repurposing Market, by End User

  • 13.1 Market Overview
  • 13.2 Pharmaceutical Companies
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Biotechnology Firms
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Research Institutes
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Contract Research Organizations
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: AI for Drug Repurposing Market, by Deployment

  • 14.1 Market Overview
  • 14.2 Cloud
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 On-Premises
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: AI for Drug Repurposing Market, by Stage

  • 15.1 Market Overview
  • 15.2 Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Preclinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Clinical Trials
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Post-Market Surveillance
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: AI for Drug Repurposing Market, by Solutions

  • 16.1 Market Overview
  • 16.2 Drug Discovery
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Drug Development
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Drug Repositioning
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: AI for Drug Repurposing Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Component
    • 17.2.7 North America Market Size and Forecast, by Application
    • 17.2.8 North America Market Size and Forecast, by End User
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by Stage
    • 17.2.11 North America Market Size and Forecast, by Solutions
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Component
      • 17.2.9.6 United States Market Size and Forecast, by Application
      • 17.2.9.7 United States Market Size and Forecast, by End User
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by Stage
      • 17.2.9.10 United States Market Size and Forecast, by Solutions
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Component
      • 17.2.10.6 Canada Market Size and Forecast, by Application
      • 17.2.10.7 Canada Market Size and Forecast, by End User
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by Stage
      • 17.2.10.10 Canada Market Size and Forecast, by Solutions
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Component
    • 17.3.7 Europe Market Size and Forecast, by Application
    • 17.3.8 Europe Market Size and Forecast, by End User
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by Stage
    • 17.3.11 Europe Market Size and Forecast, by Solutions
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Solutions
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Component
      • 17.3.10.6 Germany Market Size and Forecast, by Application
      • 17.3.10.7 Germany Market Size and Forecast, by End User
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by Stage
      • 17.3.10.10 Germany Market Size and Forecast, by Solutions
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Component
      • 17.3.11.6 France Market Size and Forecast, by Application
      • 17.3.11.7 France Market Size and Forecast, by End User
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by Stage
      • 17.3.11.10 France Market Size and Forecast, by Solutions
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Component
      • 17.3.12.6 Spain Market Size and Forecast, by Application
      • 17.3.12.7 Spain Market Size and Forecast, by End User
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by Stage
      • 17.3.12.10 Spain Market Size and Forecast, by Solutions
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Component
      • 17.3.13.6 Italy Market Size and Forecast, by Application
      • 17.3.13.7 Italy Market Size and Forecast, by End User
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by Stage
      • 17.3.13.10 Italy Market Size and Forecast, by Solutions
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Component
      • 17.3.14.6 Netherlands Market Size and Forecast, by Application
      • 17.3.14.7 Netherlands Market Size and Forecast, by End User
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.10 Netherlands Market Size and Forecast, by Solutions
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Component
      • 17.3.15.6 Sweden Market Size and Forecast, by Application
      • 17.3.15.7 Sweden Market Size and Forecast, by End User
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by Stage
      • 17.3.15.10 Sweden Market Size and Forecast, by Solutions
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Component
      • 17.3.16.6 Switzerland Market Size and Forecast, by Application
      • 17.3.16.7 Switzerland Market Size and Forecast, by End User
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.10 Switzerland Market Size and Forecast, by Solutions
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Component
      • 17.3.17.6 Denmark Market Size and Forecast, by Application
      • 17.3.17.7 Denmark Market Size and Forecast, by End User
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by Stage
      • 17.3.17.10 Denmark Market Size and Forecast, by Solutions
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Component
      • 17.3.18.6 Finland Market Size and Forecast, by Application
      • 17.3.18.7 Finland Market Size and Forecast, by End User
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by Stage
      • 17.3.18.10 Finland Market Size and Forecast, by Solutions
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Component
      • 17.3.19.6 Russia Market Size and Forecast, by Application
      • 17.3.19.7 Russia Market Size and Forecast, by End User
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by Stage
      • 17.3.19.10 Russia Market Size and Forecast, by Solutions
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Solutions
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Solutions
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Component
      • 17.4.9.6 China Market Size and Forecast, by Application
      • 17.4.9.7 China Market Size and Forecast, by End User
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by Stage
      • 17.4.9.10 China Market Size and Forecast, by Solutions
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Component
      • 17.4.10.6 India Market Size and Forecast, by Application
      • 17.4.10.7 India Market Size and Forecast, by End User
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by Stage
      • 17.4.10.10 India Market Size and Forecast, by Solutions
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Component
      • 17.4.11.6 Japan Market Size and Forecast, by Application
      • 17.4.11.7 Japan Market Size and Forecast, by End User
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by Stage
      • 17.4.11.10 Japan Market Size and Forecast, by Solutions
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Component
      • 17.4.12.6 South Korea Market Size and Forecast, by Application
      • 17.4.12.7 South Korea Market Size and Forecast, by End User
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by Stage
      • 17.4.12.10 South Korea Market Size and Forecast, by Solutions
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Component
      • 17.4.13.6 Australia Market Size and Forecast, by Application
      • 17.4.13.7 Australia Market Size and Forecast, by End User
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by Stage
      • 17.4.13.10 Australia Market Size and Forecast, by Solutions
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Component
      • 17.4.14.6 Singapore Market Size and Forecast, by Application
      • 17.4.14.7 Singapore Market Size and Forecast, by End User
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by Stage
      • 17.4.14.10 Singapore Market Size and Forecast, by Solutions
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Component
      • 17.4.15.6 Indonesia Market Size and Forecast, by Application
      • 17.4.15.7 Indonesia Market Size and Forecast, by End User
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.10 Indonesia Market Size and Forecast, by Solutions
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Component
      • 17.4.16.6 Taiwan Market Size and Forecast, by Application
      • 17.4.16.7 Taiwan Market Size and Forecast, by End User
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.10 Taiwan Market Size and Forecast, by Solutions
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Component
      • 17.4.17.6 Malaysia Market Size and Forecast, by Application
      • 17.4.17.7 Malaysia Market Size and Forecast, by End User
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.10 Malaysia Market Size and Forecast, by Solutions
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Component
    • 17.5.7 Latin America Market Size and Forecast, by Application
    • 17.5.8 Latin America Market Size and Forecast, by End User
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by Stage
    • 17.5.11 Latin America Market Size and Forecast, by Solutions
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Component
      • 17.5.9.6 Brazil Market Size and Forecast, by Application
      • 17.5.9.7 Brazil Market Size and Forecast, by End User
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by Stage
      • 17.5.9.10 Brazil Market Size and Forecast, by Solutions
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Component
      • 17.5.10.6 Mexico Market Size and Forecast, by Application
      • 17.5.10.7 Mexico Market Size and Forecast, by End User
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by Stage
      • 17.5.10.10 Mexico Market Size and Forecast, by Solutions
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Component
      • 17.5.11.6 Argentina Market Size and Forecast, by Application
      • 17.5.11.7 Argentina Market Size and Forecast, by End User
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by Stage
      • 17.5.11.10 Argentina Market Size and Forecast, by Solutions
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Solutions
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Solutions
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Solutions
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Component
      • 17.6.10.6 UAE Market Size and Forecast, by Application
      • 17.6.10.7 UAE Market Size and Forecast, by End User
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by Stage
      • 17.6.10.10 UAE Market Size and Forecast, by Solutions
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Component
      • 17.6.11.6 South Africa Market Size and Forecast, by Application
      • 17.6.11.7 South Africa Market Size and Forecast, by End User
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by Stage
      • 17.6.11.10 South Africa Market Size and Forecast, by Solutions
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Solutions
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 BioNTech
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Moderna
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Gritstone Oncology
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Neon Therapeutics
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Immunicum
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Ultimovacs
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Vaccibody
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Transgene
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Nouscom
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Agenus
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 AgenTus Therapeutics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 OncoSec Medical
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Inovio Pharmaceuticals
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Hookipa Pharma
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Aduro Biotech
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 CureVac
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Genexine
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 OncoPep
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Vaximm
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 eTheRNA Immunotherapies
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis